Clinical Trials Browser

Phase 2 × NIH × Recurrent Bladder Urothelial Carcinoma × Clear all

NCT02844816 2025-05-22

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Phase 2 Completed

172 enrolled 16 charts

Recurrent Bladder Urothelial Carcinoma